Solitary fibrous tumor arising from the prostatic capsuleNOGUCHI, Masanori; HIRABAYASHI, Yasuo; KATO, Seiya et al.The Journal of urology. 2002, Vol 168, Num 4, pp 1490-1491, issn 0022-5347, 1Article

Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancerNOGUCHI, Masanori; NODA, Shinshi.The Journal of urology. 2001, Vol 166, Num 3, pp 1106-1110, issn 0022-5347Conference Paper

Serum levels of bone turnover markers parallel the results of bone scintigraphy in monitoring bone activity of prostate cancerNOGUCHI, Masanori; YAHARA, Jyunro; NODA, Shinshi et al.Urology (Ridgewood, NJ). 2003, Vol 61, Num 5, pp 993-998, issn 0090-4295, 6 p.Article

Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24⁺ prostate cancer patientsKOBAYASHI, Kazuhiko; NOGUCHI, Masanori; ITOH, Kyogo et al.Cancer science. 2003, Vol 94, Num 7, pp 622-627, issn 1347-9032, 6 p.Article

Spontaneous shunt between the superior mesenteric vein and the right renal vein caused by portal hypertensionKIKUCHI, Hidezumi; NOGUCHI, Masanori; AKASHI, Hidetoshi et al.The Journal of urology. 2001, Vol 165, Num 5, pp 1615-1616, issn 0022-5347Article

No residual tumor in a radical prostatectomy specimen after neoadjuvant hormonal therapy for localized prostate cancerNOGUCHI, Masanori; NODA, Shinshi; NAKASHIMA, Osamu et al.Oncology reports. 2002, Vol 9, Num 5, pp 1075-1080, issn 1021-335XArticle

Vaccination of cytotoxic T lymphocyte-directed peptides elicited and spread humoral and Th1-type immune responses to prostate-specific antigen protein in a prostate cancer patientHARADA, Mamoru; MATSUEDA, Satoko; YAO, Akihisa et al.Journal of immunotherapy (1997). 2005, Vol 28, Num 4, pp 368-375, issn 1524-9557, 8 p.Article

Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: Lack of significance of secondary cancersNOGUCHI, Masanori; STAMEY, Thomas A; MCNEAL, John E et al.The Journal of urology. 2003, Vol 170, Num 2, pp 459-463, issn 0022-5347, 5 p., 1Article

Phase II Study of Personalized Peptide Vaccination for Castration-Resistant Prostate Cancer Patients Who Failed in Docetaxel-Based ChemotherapyNOGUCHI, Masanori; MORIYA, Fukuko; SUEKANE, Shigetaka et al.The Prostate. 2012, Vol 72, Num 8, pp 834-845, issn 0270-4137, 12 p.Article

Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccinesSASADA, Tetsuro; KOMATSU, Nobukazu; SUEKANE, Shigetaka et al.European journal of cancer (1990). 2010, Vol 46, Num 9, pp 1514-1519, issn 0959-8049, 6 p.Article

Capability of SART3_109-118 peptide to induce cytotoxic T lymphocytes from prostate cancer patients with HLA class I-AII, -A31 and -A33 allelesELNISR RASHED MOHAMED; NAITO, Masayasu; TERASAKI, Yasunobu et al.International journal of oncology. 2009, Vol 34, Num 2, pp 529-536, issn 1019-6439, 8 p.Article

New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype allelesMATSUEDA, Satoko; TAKEDATSU, Hiroko; SASADA, Tetsuro et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 3, pp 274-281, issn 1524-9557, 8 p.Article

Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2⁺ prostate cancer patientsHARADA, Mamoru; MATSUEDA, Satoko; YAO, Akihisa et al.Oncology reports. 2004, Vol 12, Num 3, pp 601-607, issn 1021-335X, 7 p.Article

A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatinMATSUMOTO, Kazumasa; NOGUCHI, Masanori; SATOH, Takefumi et al.BJU international (Papier). 2011, Vol 108, Num 6, pp 831-838, issn 1464-4096, 8 p.Article

Identification of peptides applicable as vaccines for HLA-A26-positive cancer patientsNIU, Yamei; TERASAKI, Yasunobu; KOMATSU, Nobukazu et al.Cancer science. 2009, Vol 100, Num 11, pp 2167-2174, issn 1347-9032, 8 p.Article

Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype allelesMATSUEDA, Satoko; TAKEDATSU, Hiroko; YAO, Akihisa et al.Clinical cancer research. 2005, Vol 11, Num 19, pp 6933-6943, issn 1078-0432, 11 p., 1Article

New epitope peptides derived from parathyroid hormone-related protein which have the capacity to induce prostate cancer-reactive cytotoxicT lymphocytes in HLA-A2⁺ prostate cancer patientsYAO, Akihisa; HARADA, Mamoru; ITOH, Kyogo et al.The Prostate. 2005, Vol 62, Num 3, pp 233-242, issn 0270-4137, 10 p.Article

Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2⁺ patients with hormone-refractory prostate cancerMATSUEDA, Satoko; KOBAYASHI, Kazuhiko; NONAKA, Yoichi et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 6, pp 479-489, issn 0340-7004, 11 p.Article

Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancersNOGUCHI, Masanori; STAMEY, Thomas A; MCNEAL, John E et al.The Journal of urology. 2000, Vol 164, Num 5, pp 1596-1600, issn 0022-5347Article

Gene Expression Profiles in Peripheral Blood as a Biomarker in Cancer Patients Receiving Peptide VaccinationKOMATSU, Nobukazu; MATSUEDA, Satoko; MATSUOKA, Kei et al.Cancer. 2012, Vol 118, Num 12, pp 3208-3221, issn 0008-543X, 14 p.Article

An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 allelesTERASAKI, Yasunobu; SHICHIJO, Shigeki; YAMEI NIU et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 11, pp 1877-1885, issn 0340-7004, 9 p.Article

A randomized clinical trial of suspension technique for improving early recovery of urinary continence after radical retropubic prostatectomyNOGUCHI, Masanori; KAKUMA, Tatsuyuki; SUEKANE, Shigetaka et al.BJU international (Papier). 2008, Vol 102, Num 8, pp 958-963, issn 1464-4096, 6 p.Article

Identification of polycomb group protein enhancer of zeste homolog 2 (EZH2)-derived peptides immunogenic in HLA-A24⁺ prostate cancer patientsOGATA, Rika; MATSUEDA, Satoko; YAO, Akihisa et al.The Prostate. 2004, Vol 60, Num 4, pp 273-281, issn 0270-4137, 9 p.Article

Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancerNOGUCHI, Masanori; ITOH, Kyogo; SUEKANE, Shigetaka et al.Cancer science. 2004, Vol 95, Num 1, pp 77-84, issn 1347-9032, 8 p.Article

Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens : Lack of prediction of tumor significance for men with nonpalpable prostate cancer. Commentaries. Authors' replyNOGUCHI, Masanori; STAMEY, Thomas A; MCNEAL, John E et al.The Journal of urology. 2001, Vol 166, Num 1, pp 104-110, issn 0022-5347Article